Display options
Cite
Monteillier A, Loucif A, Omoto K, et al. Corrigendum to "Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1" [Bioorg. Med. Chem. Lett. 26 (2016) 4919-4924]. Bioorg Med Chem Lett. 2017;27(9):2082doi: 10.1016/j.bmcl.2017.02.063.
Monteillier, A., Loucif, A., Omoto, K., Stevens, E. B., Lainez, S., Saintot, P. P., Cao, L., & Pryde, D. C. (2017). Corrigendum to "Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1" [Bioorg. Med. Chem. Lett. 26 (2016) 4919-4924]. Bioorganic & medicinal chemistry letters, 27(9), 2082. https://doi.org/10.1016/j.bmcl.2017.02.063
Monteillier, Aymeric, et al. "Corrigendum to "Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1" [Bioorg. Med. Chem. Lett. 26 (2016) 4919-4924]." Bioorganic & medicinal chemistry letters vol. 27,9 (2017): 2082. doi: https://doi.org/10.1016/j.bmcl.2017.02.063
Monteillier A, Loucif A, Omoto K, Stevens EB, Lainez S, Saintot PP, Cao L, Pryde DC. Corrigendum to "Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1" [Bioorg. Med. Chem. Lett. 26 (2016) 4919-4924]. Bioorg Med Chem Lett. 2017 May 01;27(9):2082. doi: 10.1016/j.bmcl.2017.02.063. Epub 2017 Mar 17. PMID: 28320618.
Copy Download .nbib Format: NLM
Share it on

Bioorg Med Chem Lett. 2017 May 01;27(9):2082. doi: 10.1016/j.bmcl.2017.02.063. Epub 2017 Mar 17.

Corrigendum to "Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1" [Bioorg. Med. Chem. Lett. 26 (2016) 4919-4924].

Bioorganic & medicinal chemistry letters

Aymeric Monteillier, Alexandre Loucif, Kiyoyuki Omoto, Edward B Stevens, Sergio Lainez, Pierre-Philippe Saintot, Lishuang Cao, David C Pryde

Affiliations

  1. Pfizer Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridge CB21 6GS, UK.
  2. Worldwide Medicinal Chemistry, Pfizer Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridge CB21 6GS, UK.
  3. Worldwide Medicinal Chemistry, Pfizer Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridge CB21 6GS, UK. Electronic address: [email protected].

PMID: 28320618 DOI: 10.1016/j.bmcl.2017.02.063

[No abstract available.]

Publication Types